A different tune: Cellular IPOD plays role in prion biology

Apr 28, 2010 by Nicole Giese

(PhysOrg.com) -- Cells take advantage of a biologically ancient compartment to sequester prions, an action that can initially prevent the prions’ phenotypic expression, according to Whitehead Institute researchers. While in this compartment, less heritable prion plaques mature to a more transmissible state.

“A transitional state for prions, when a prion is not heritable and infectious, has been suggested before, but it was not known that this transition state is already the true prion conformation, because it was hard to imagine how something could already be the prion conformation, but not yet have the traits of a true prion -- infectivity, heritability, and ability to create a phenotype.” says Jens Tyedmers, a former postdoctoral researcher in the lab of Whitehead Member Susan Lindquist. “This is the first time anyone has really demonstrated the nature of this transitional state and how it works.”

This research is reported by Tyedmers in this week’s early online edition of the journal PNAS.

According to Whitehead Member Susan Lindquist, the results of this study may have broader implications for understanding the cellular mechanisms of prion organization and the retention of damaged proteins.

Prions are a type of misfolded protein that can convert normal copies of that protein to a misfolded shape. As the misfolded copies accumulate in a cell, they stick together to form a long chain or clump in the cell. Although best known for causing such as Creutzfeldt-Jakob disease (CJD) in humans, (BSE, or “”) in cows, and scrapie in sheep, prions can and do exist naturally in many organisms, including yeast. In yeast, prions can change a cell’s phenotypes for better or worse. And this can have important implications for the evolution of new traits in yeast.

By looking at prion-producing , Tyedmers noted that both long prion chains and prion clumps were associated with a biologically ancient compartment called IPOD, for “insoluble protein deposit”. When Tyedmers first turned on prion production in the cells, long prion chains began in the IPOD, and then extended beyond the IPOD as ribbons, which were bounded by the cells’ membranes to form rings. After many generations, the ring form turned into prion clumps that look like dots in the cells. These dots were a hodgepodge of numerous, very short prion chains that remained confined within the IPOD.

Tyedmers and his colleagues believe that the IPOD serves as a depository for damaged and hopelessly misfolded protein aggregates, including prions. Eventually, these proteins may either be chopped up by the enzyme Hsp104 or remain contained in the IPOD until the cell dies. The IPOD may also retain problem proteins throughout cell division. As the original mother cell divides, an IPOD full of damaged and potentially harmful proteins remains in the mother cell, thereby allowing the daughter cell to begin life without the burden of potentially toxic proteins.

Yet, the IPOD does not prevent prion inheritance. Tyedmers found that the dot state is almost always passed from the original mother cell to its daughter cell, whereas the ring state is less frequently passed to the daughter cells. This difference in heritability combined with the eventual conversion from ring form to dot form over many generations suggests that the ring form is a transitional prion state.

Sebastian Treusch, who is second author on the paper, explains that the Hsp104 enzyme is responsible for the inheritance of both prion forms and plays an important role in the conversion of rings to dots.

“The enzyme chops up long prion fibers into shorter fibers, at some rate generating little specks of prion, or prion seeds, that can freely diffuse into the future daughter cell,” says Treusch. “The ring state has longer prion fibers. This makes them less heritable as they are more easily captured in the mother cell.”

“This means the prion has evolved to escape the damage retention in the mother,” says Tyedmers. “This works most efficiently when the cleavage rate is very high, as in the dot form’s case.”

According to Lindquist, who is also a professor of biology at MIT and a Howard Hughes Medical Institute Investigator, the IPOD has been evolutionarily retained from yeast through higher organisms. Therefore, the results of this study may have broader implications for understanding the cellular mechanisms of prion organization and the retention of damaged proteins.

Explore further: Researchers take 'first baby step' toward anti-aging drug

More information: Jens Tyedmers et al., “Prion induction involves an ancient system for the sequestration of aggregated proteins and heritable changes in prion fragmentation”, PNAS, April 26, 2010.

Related Stories

Prions show their good side

May 07, 2008

Prions, the infamous agents behind mad cow disease and its human variation, Creutzfeldt-Jakob Disease, also have a helpful side. According to new findings from Gerald Zamponi and colleagues, normally functioning prions prevent ...

Prion propagates in foreign host

Jul 05, 2007

Prions -- infectious, oddly-folded proteins that are the main suspects in fatal neurodegenerative diseases such as Cruetzfeldt-Jakob and bovine spongiform encephalopathy, or "mad cow" -- remain mostly a mystery to scientists. ...

Prions serve as important source of variation in nature

Apr 02, 2009

Special proteins known as prions, which are perhaps best known as the agents of mad cow and other neurodegenerative diseases, can also serve as an important source of beneficial variation in nature, confirms a new study in ...

Prion switching in response to environmental stress

Nov 25, 2008

If you have had a hard day at work, you may change your eating habits, perhaps favoring comfort food, but you don't suddenly develop the ability to eat the plate and cutlery. A new paper, published in this week's issue of ...

Recommended for you

Biomedical team creates 'nerve on a chip'

Dec 24, 2014

Michael J. Moore and J. Lowry Curley first met in the laboratory as professor and student. Now the two Tulane University researchers have started a new biomedical company that's winning praise and awards.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.